ATE480265T1 - Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen - Google Patents
Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellenInfo
- Publication number
- ATE480265T1 ATE480265T1 AT05786212T AT05786212T ATE480265T1 AT E480265 T1 ATE480265 T1 AT E480265T1 AT 05786212 T AT05786212 T AT 05786212T AT 05786212 T AT05786212 T AT 05786212T AT E480265 T1 ATE480265 T1 AT E480265T1
- Authority
- AT
- Austria
- Prior art keywords
- fibroblas
- dental
- vascular cells
- treat vascular
- treat
- Prior art date
Links
- 210000005167 vascular cell Anatomy 0.000 title 1
- 206010002329 Aneurysm Diseases 0.000 abstract 1
- 206010065558 Aortic arteriosclerosis Diseases 0.000 abstract 1
- 208000002251 Dissecting Aneurysm Diseases 0.000 abstract 1
- 208000031481 Pathologic Constriction Diseases 0.000 abstract 1
- 201000001962 aortic atherosclerosis Diseases 0.000 abstract 1
- 206010002895 aortic dissection Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
- 208000037804 stenosis Diseases 0.000 abstract 1
- 230000036262 stenosis Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0407357A FR2872431B1 (fr) | 2004-07-02 | 2004-07-02 | Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire |
| PCT/FR2005/001690 WO2006013261A2 (fr) | 2004-07-02 | 2005-07-01 | Utilisation de fibroblastes gingivaux en therapie cellulaire vasculaire. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE480265T1 true ATE480265T1 (de) | 2010-09-15 |
Family
ID=34946541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05786212T ATE480265T1 (de) | 2004-07-02 | 2005-07-01 | Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8119122B2 (de) |
| EP (1) | EP1773420B1 (de) |
| JP (1) | JP4891903B2 (de) |
| AT (1) | ATE480265T1 (de) |
| AU (1) | AU2005268746B2 (de) |
| CA (1) | CA2572554C (de) |
| DE (1) | DE602005023468D1 (de) |
| DK (1) | DK1773420T3 (de) |
| ES (1) | ES2354220T3 (de) |
| FR (1) | FR2872431B1 (de) |
| WO (1) | WO2006013261A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010500335A (ja) | 2006-08-10 | 2010-01-07 | ユニベルシテ ルネ デカルト−パリ サンク | 皮膚創傷を治療する方法 |
| EP1972685B1 (de) | 2007-03-20 | 2015-09-02 | Université Paris Descartes | Kulturmedium für Zahnfleischfibroblasten |
| EP2205226B1 (de) * | 2007-10-09 | 2020-05-13 | Université Paris Descartes | Vorrichtung zur verabreichung von zellen |
| JP2011526585A (ja) * | 2008-03-31 | 2011-10-13 | スカルセル テラピュティク | 皮膚の老化の美容的処置法 |
| US20120100111A1 (en) * | 2009-03-06 | 2012-04-26 | Universite Paris Descartes | Method for treating cancer |
| WO2011012575A1 (en) | 2009-07-27 | 2011-02-03 | Scarcell Therapeutics | Balloon catheter device |
| FR3008316B1 (fr) | 2013-07-09 | 2020-01-31 | Assistance Publique - Hopitaux De Paris | Utilisation de fibroblastes gingivaux dans le traitement de l'alopecie |
| CN109104869B (zh) * | 2016-04-27 | 2022-07-01 | 日本乐敦制药株式会社 | 表达细胞表面标记物的间充质干细胞、包含该间充质干细胞的药物组合物及其制备方法 |
| WO2018091698A1 (en) * | 2016-11-18 | 2018-05-24 | Scarcell Therapeutics | Compositions useful for the treatment of immune-related diseases |
| CN113164783A (zh) * | 2018-11-30 | 2021-07-23 | 株式会社资生堂 | 用于治疗或预防皮肤的色素沉积的组合物 |
| JP2026509514A (ja) | 2023-03-15 | 2026-03-19 | スカーセル セラピューティクス エスアーエス | 哺乳動物における細胞治療のための哺乳動物細胞集団および医薬、ならびに改善された細胞培養法 |
| WO2024189522A1 (en) | 2023-03-15 | 2024-09-19 | Scarcell Therapeutics | Mammalian cell population and medicaments for cell therapies in mammals and improved cell cultivation methods |
| US12351823B2 (en) | 2023-03-15 | 2025-07-08 | Scarcell Technologies | Mammalian cell population and medicaments for cell therapies in equines and improved cell cultivation methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2678945B2 (ja) * | 1989-04-17 | 1997-11-19 | 有限会社ナイセム | 人工血管とその製造方法及び人工血管用基質 |
| US5891558A (en) * | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
| WO1997045533A1 (en) * | 1996-05-28 | 1997-12-04 | The Regents Of The University Of Michigan | Engineering oral tissues |
| AU3118499A (en) * | 1998-04-03 | 1999-10-25 | Beth Israel Deaconess Medical Center | Soft tissue reconstructor and method of use |
| WO2001082773A2 (en) * | 2000-04-28 | 2001-11-08 | The Regents Of The University Of California | Structures useful for bone engineering and methods |
| US20040101959A1 (en) * | 2002-11-21 | 2004-05-27 | Olga Marko | Treatment of tissue with undifferentiated mesenchymal cells |
-
2004
- 2004-07-02 FR FR0407357A patent/FR2872431B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-01 JP JP2007519832A patent/JP4891903B2/ja not_active Expired - Lifetime
- 2005-07-01 ES ES05786212T patent/ES2354220T3/es not_active Expired - Lifetime
- 2005-07-01 WO PCT/FR2005/001690 patent/WO2006013261A2/fr not_active Ceased
- 2005-07-01 AT AT05786212T patent/ATE480265T1/de not_active IP Right Cessation
- 2005-07-01 EP EP05786212A patent/EP1773420B1/de not_active Expired - Lifetime
- 2005-07-01 DE DE602005023468T patent/DE602005023468D1/de not_active Expired - Lifetime
- 2005-07-01 AU AU2005268746A patent/AU2005268746B2/en not_active Expired
- 2005-07-01 CA CA2572554A patent/CA2572554C/fr not_active Expired - Lifetime
- 2005-07-01 US US11/571,542 patent/US8119122B2/en active Active
- 2005-07-01 DK DK05786212.0T patent/DK1773420T3/da active
-
2012
- 2012-01-06 US US13/345,624 patent/US8609085B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008505164A (ja) | 2008-02-21 |
| FR2872431B1 (fr) | 2007-07-20 |
| EP1773420B1 (de) | 2010-09-08 |
| CA2572554A1 (fr) | 2006-02-09 |
| JP4891903B2 (ja) | 2012-03-07 |
| US8119122B2 (en) | 2012-02-21 |
| ES2354220T3 (es) | 2011-03-11 |
| US20120177613A1 (en) | 2012-07-12 |
| DK1773420T3 (da) | 2011-01-10 |
| US8609085B2 (en) | 2013-12-17 |
| EP1773420A2 (de) | 2007-04-18 |
| DE602005023468D1 (de) | 2010-10-21 |
| WO2006013261A3 (fr) | 2006-06-15 |
| US20080025954A1 (en) | 2008-01-31 |
| WO2006013261A2 (fr) | 2006-02-09 |
| AU2005268746A1 (en) | 2006-02-09 |
| FR2872431A1 (fr) | 2006-01-06 |
| CA2572554C (fr) | 2013-09-10 |
| AU2005268746B2 (en) | 2011-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004017736D1 (de) | Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust | |
| DE60314500D1 (de) | Diaminopyrimidine und deren verwendung als angiogenesehemmer | |
| ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
| DE602004015811D1 (de) | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden | |
| ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
| ATE554725T1 (de) | Chirurgische artikel zur behandlung von beckenerkrankungen | |
| ATE530142T1 (de) | Chirurgische artikel zur behandlung von beckenerkrankungen | |
| ATE523196T1 (de) | Mitotische kinesinhemmer und verfahren zu ihrer verwendung | |
| DE602005023468D1 (de) | Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen | |
| WO2007030743A3 (en) | Cochlear implants containing biological cells and uses thereof | |
| DE602004028587D1 (de) | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR siRNA-HEMMUNG VON ICAM-1 | |
| ATE471334T1 (de) | Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs | |
| ATE555380T1 (de) | Verfahren zur änderung des schicksals von zellen | |
| DE602004012816D1 (de) | Selbstexpandierbarer Stent und Stenteinbringungssystem zur Behandlung von Gefässerkrankungen | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| DE602005015862D1 (de) | Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien | |
| DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| DE602004022036D1 (de) | Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen | |
| DE602005019247D1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
| DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
| ATE487487T1 (de) | Verwendung von verbindungen, die die ef-tu- nucleolin wechselwirkung vehindern, zur verhinderung oder behandlung von tularämie | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| DE602005015160D1 (de) | Stent-Graft zur Behandlung von Aneurysmen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |